Relay Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Relay Therapeutics, Inc. (RLAY) on January 9, 2023. The filing serves as a Regulation FD disclosure regarding the Company's participation in the 41st Annual J.P. Morgan Healthcare Conference scheduled for the week of January 9, 2023.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the presentation of conference materials and does not contain financial statements or operational data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the furnishing of presentation slides (Exhibit 99.1) related to the upcoming conference.
Guidance, Outlook, and Risks
The filing incorporates by reference the presentation slides furnished as Exhibit 99.1, which may contain forward-looking statements, guidance, or management commentary. However, the text of this 8-K explicitly states that the information in Item 7.01 and Exhibit 99.1 is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, nor is it subject to the liabilities of that section. No specific risks or contingencies are detailed within the body of this report.
Key Facts for Investor Verification
- Review Exhibit 99.1 (41st Annual J.P. Morgan Healthcare Conference Presentation) for actual business updates, pipeline data, and financial guidance.
- Note that the presentation materials are furnished and not deemed "filed" under the Exchange Act, limiting their legal liability status compared to formal filings.
- Verify the date of the conference (week of January 9, 2023) to ensure any data presented is current.